4-(3,4-dimethylcyclopentyl)-6-[4-(2,4-dimethyl-3,4-dihydropyrazol-5-yl)piperidin-1-yl]-2-(trifluoromethyl)pyrimidine
C22H32F3N5 — CID 174339530
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(3,4-dimethylcyclopentyl)-6-[4-(2,4-dimethyl-3,4-dihydropyrazol-5-yl)piperidin-1-yl]-2-(trifluoromethyl)pyrimidine
4-(3,4-dimethylcyclopentyl)-6-[4-(2,4-dimethyl-3,4-dihydropyrazol-5-yl)piperidin-1-yl]-2-(trifluoromethyl)pyrimidine (PubChem CID 174339530) has the molecular formula C22H32F3N5 and a molecular weight of 423.53 g/mol. Its IUPAC name is 4-(3,4-dimethylcyclopentyl)-6-[4-(2,4-dimethyl-3,4-dihydropyrazol-5-yl)piperidin-1-yl]-2-(trifluoromethyl)pyrimidine.
Molecular Properties
| Compound Name | 4-(3,4-dimethylcyclopentyl)-6-[4-(2,4-dimethyl-3,4-dihydropyrazol-5-yl)piperidin-1-yl]-2-(trifluoromethyl)pyrimidine |
|---|---|
| PubChem CID | 174339530 |
| Molecular Formula | C22H32F3N5 |
| Molecular Weight | 423.53 g/mol |
| Exact Mass | 423.26 |
| IUPAC Name | 4-(3,4-dimethylcyclopentyl)-6-[4-(2,4-dimethyl-3,4-dihydropyrazol-5-yl)piperidin-1-yl]-2-(trifluoromethyl)pyrimidine |
| SMILES | CC1CN(C)N=C1C1CCN(c2cc(C3CC(C)C(C)C3)nc(C(F)(F)F)n2)CC1 |
| InChI | InChI=1S/C22H32F3N5/c1-13-9-17(10-14(13)2)18-11-19(27-21(26-18)22(23,24)25)30-7-5-16(6-8-30)20-15(3)12-29(4)28-20/h11,13-17H,5-10,12H2,1-4H3 |
| InChIKey | QMSSQKPLQSEVGG-UHFFFAOYSA-N |
| XLogP | 4.80 |
| TPSA | 44.62 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 423.53 |
| LogP ≤ 5 | 4.80 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174339530 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.